Vuno Inc. (KOSDAQ:338220)
South Korea · Delayed Price · Currency is KRW 19,160
-890 (-4.44%)
At close: Feb 6, 2026
Vuno Inc. Revenue
Vuno Inc. had revenue of 10.82B KRW in the quarter ending September 30, 2025, with 57.66% growth. This brings the company's revenue in the last twelve months to 34.69B, up 46.26% year-over-year. In the year 2024, Vuno Inc. had annual revenue of 25.87B with 94.86% growth.
Revenue (ttm)
34.69B
Revenue Growth
+46.26%
P/S Ratio
7.73
Revenue / Employee
228.24M
Employees
152
Market Cap
268.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.87B | 12.59B | 94.86% |
| Dec 31, 2023 | 13.28B | 5.00B | 60.44% |
| Dec 31, 2022 | 8.27B | 6.03B | 268.10% |
| Dec 31, 2021 | 2.25B | 990.66M | 78.80% |
| Dec 31, 2020 | 1.26B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 120.30B |
| MEDIANA Co.,Ltd | 59.83B |
| L&K Biomed | 40.33B |
| ASTERASYS Co.,Ltd | 36.47B |
| Hironic | 33.18B |
| SELVAS Healthcare | 29.79B |
| Remed | 24.26B |
| Neofect | 20.50B |